Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Villeirs

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Cancers|February 13, 2026
Does It Make Sense to Perform Prostate Magnetic Resonance Imaging in Men with Normal PSA (<4 ng/mL)?Pieter De Visschere, Camille Berquin, Pieter De Backer, et al.
European Urology Open Science|August 2, 2021
The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) RegistryNicolaas Lumen, Elise De Bleser, Sarah Buelens, et al.
European Radiology|May 15, 2021
ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imagingTobias Penzkofer, Anwar R Padhani, Baris Turkbey, et al.
Radiology|June 12, 2019
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy PathwayAnwar R Padhani, Jelle Barentsz, Geert Villeirs, et al.
Urologia Internationalis|February 2, 2026
Pelvic lymph node dissection during radical prostatectomy for prostate cancer: harms versus benefitsEva Donck, Claudia Fede Spicchiale, Tong Yang, et al.
European Urology Focus|February 19, 2025
Adjuvant Radiotherapy After Radical Cystectomy for Muscle-invasive Bladder Cancer: A Phase 2 Trial-Results of Secondary EndpointsFlor Verghote, Elke Rammant, Piet Dirix, et al.
BMC Cancer|October 19, 2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trialFlor Verghote, Lindsay Poppe, Sofie Verbeke, et al.
European Urology|March 23, 2019
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2Baris Turkbey, Andrew B Rosenkrantz, Masoom A Haider, et al.
BJU International|January 26, 2019
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essayCharlien Berghen, Maarten Albersen, Pierre Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialPiet Ost, Dries Reynders, Karel Decaestecker, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Cancers|February 13, 2026
Does It Make Sense to Perform Prostate Magnetic Resonance Imaging in Men with Normal PSA (<4 ng/mL)?Pieter De Visschere, Camille Berquin, Pieter De Backer, et al.
European Urology Open Science|August 2, 2021
The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) RegistryNicolaas Lumen, Elise De Bleser, Sarah Buelens, et al.
European Radiology|May 15, 2021
ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imagingTobias Penzkofer, Anwar R Padhani, Baris Turkbey, et al.
Radiology|June 12, 2019
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy PathwayAnwar R Padhani, Jelle Barentsz, Geert Villeirs, et al.
Urologia Internationalis|February 2, 2026
Pelvic lymph node dissection during radical prostatectomy for prostate cancer: harms versus benefitsEva Donck, Claudia Fede Spicchiale, Tong Yang, et al.
European Urology Focus|February 19, 2025
Adjuvant Radiotherapy After Radical Cystectomy for Muscle-invasive Bladder Cancer: A Phase 2 Trial-Results of Secondary EndpointsFlor Verghote, Elke Rammant, Piet Dirix, et al.
BMC Cancer|October 19, 2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trialFlor Verghote, Lindsay Poppe, Sofie Verbeke, et al.
European Urology|March 23, 2019
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2Baris Turkbey, Andrew B Rosenkrantz, Masoom A Haider, et al.
BJU International|January 26, 2019
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essayCharlien Berghen, Maarten Albersen, Pierre Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialPiet Ost, Dries Reynders, Karel Decaestecker, et al.
Pageof 10